Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer

被引：16
|
作者：
Melosky, Barbara [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver Ctr, Med Oncol, 600 West 10th Ave, Vancouver, BC V5Z 4E6, Canada
来源：
FRONTIERS IN ONCOLOGY | 2014年 / 4卷
关键词：
metatstatic non-squamous NSCLC; systemic therapy; chemotherapy; targeted therapy;
D O I：
10.3389/fonc.2014.00256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A number of developments have altered the treatment paradigm for metastatic non-small cell, non-squamous lung cancer. These include increasing knowledge of molecular signal pathways, as well as the outcomes of several large-scale trials. As a result, treatments are becoming more efficacious and more personalized, and are changing the management and prognosis of non-small cell lung cancer patients. This is resulting in increased survival in select patient groups. In this paper, a simplified algorithm for treating patients with metastatic non-small cell, non-squamous lung cancer is presented.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
    Melosky, Barbara
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
  • [2] Management and treatment costs of non-squamous metastatic or locally advanced non-small cell lung cancer
    Pruszko, Cezary
    Jachimowicz, Michal
    Kalinowska, Agnieszka
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 (02): : 63 - 67
  • [3] Atezolizumab in non-squamous non-small cell lung cancer
    Akamine, Takaki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Seto, Takashi
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S3155 - S3159
  • [4] EGFR mutations and gefitinib sensitivity in patients with metastatic non-squamous non-small cell lung cancer
    Moiseyenko, V.
    Imyanitov, E.
    Levchenko, E.
    Procenko, S.
    Orlova, R.
    Iyevleva, A.
    Buslov, K.
    Ulibina, Y.
    Matsko, D.
    Moiseyenko, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Molecular testing in older patients treated for an advanced or metastatic non-squamous non-small cell lung cancer
    Lamy, T.
    Cabarrou, B.
    Planchard, D.
    Quantin, X.
    Schneider, S.
    Bringuier, M.
    Besse, B.
    Perol, M.
    Girard, N.
    Schott, R.
    Chouaid, C.
    Ricordel, C.
    Gervais, R.
    Debieuvre, D.
    Audigier-Valette, C.
    Carton, M.
    Filleron, T.
    Simon, G.
    Robain, M.
    Baldini, C.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1243 - S1244
  • [6] Maintenance chemotherapy in patients with non-squamous non-small cell lung cancer (NSCLC)
    Belalcazar, A.
    Santos, E. S.
    Gomez, J. E.
    Lopez, E.
    Raez, L. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    [J]. LUNG CANCER, 2019, 135 : 104 - 109
  • [8] Cemiplimab monotherapy in advanced non-squamous and squamous non-small cell lung cancer
    Rosell, Rafael
    Gonzalez-Cao, Maria
    [J]. LANCET, 2021, 397 (10274): : 557 - 559
  • [9] A Phase II Study of Metformin with Pemetrexed/Carboplatin in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer
    Verma, S.
    Malik, P. S.
    Kalra, K.
    Singh, V.
    Kumar, S.
    Khurana, S.
    Pushpam, D.
    Jain, D.
    Gupta, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S130 - S131
  • [10] Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Chen, Yongshun
    Wen, Qinglian
    Liu, Hao
    Ao, Rui
    Wu, Xiaoyuan
    Guo, Leiming
    Wang, Wen
    He, Chunyu
    Wang, Jianhua
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 553 - 557
12345